Hospital readmission and mortality in chinese patients with heart failure stratified by ejection fraction levels after treatment with sacubitril/valsartan

被引:0
|
作者
Ye, X. [1 ]
Chan, E. S. Y. [2 ]
Man, K. K. C. [2 ]
Wong, C. K. [3 ]
Tse, H. F. [3 ]
Chan, E. W. [1 ]
机构
[1] Univ Hong Kong, Dept Pharmacol & Pharm, Ctr Safe Medicat Practice & Res, Hong Kong, Peoples R China
[2] UCL, Sch Pharm, London, England
[3] Univ Hong Kong, Sch Clin Med, LKS Fac Med, Dept Med, Hong Kong, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:91 / 92
页数:2
相关论文
共 50 条
  • [21] Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure and Reduced Ejection Fraction Treated with Sacubitril/Valsartan
    Diez-Villanueva, Pablo
    Vicent, Lourdes
    de la Cuerda, Francisco
    Esteban-Fernandez, Alberto
    Gomez-Bueno, Manuel
    de Juan-Baguda, Javier
    Manuel Iniesta, Angel
    Ayesta, Ana
    Rojas-Gonzalez, Antonio
    Bover-Freire, Ramon
    Iglesias, Diego
    Garcia-Aguado, Marcos
    Angel Perea-Egido, Jesus
    Salamanca, Jorge
    Martinez-Selles, Manuel
    CARDIOLOGY, 2020, 145 (05) : 275 - 282
  • [22] Reduction of Pulmonary Hypertension After Transition to Sacubitril/Valsartan in Patients With Heart Failure With Preserved Ejection Fraction
    Burgdorf, Christof
    Brockmoeller, Janine
    Strampe, Henrieke
    Januszewski, Monika
    Remppis, Bjoern Andrew
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [23] Impact of sacubitril/valsartan treatment on depression and anxiety in heart failure with reduced ejection fraction
    Dereli, Seckin
    Kilincel, Oguzhan
    Cerik, Idris Bugra
    Kaya, Ahmet
    ACTA CARDIOLOGICA, 2020, 75 (08) : 774 - 782
  • [24] Ventricular-arterial coupling and sacubitril/valsartan treatment in patients with heart failure and reduced ejection fraction
    Lavall, Daniel
    Stegmann, T.
    Parentin, L.
    Hagendorff, A.
    Schirmer, S. H.
    Laufs, U.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 51 - 51
  • [25] Cost-effectiveness of sacubitril/valsartan for the treatment of patients with heart failure with reduced ejection fraction in Portugal
    Borges, Margarida
    Afonso-Silva, Marta
    Laires, Pedro A.
    Gouveia, Miguel
    Alarcao, Joana
    Ascencao, Raquel
    Costa, Joao
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2020, 20 (02) : 199 - 205
  • [26] Combined treatment with sacubitril/valsartan plus dapagliflozin in patients affected by heart failure with reduced ejection fraction
    Jiang, Juan
    Gao, Jie
    Zhang, Xiuzhen
    Li, Yuanmin
    Dang, Heqin
    Liu, Yanlin
    Chen, Wenwen
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [27] Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
    McMurray, John J. V.
    Trueman, David
    Hancock, Elizabeth
    Cowie, Martin R.
    Briggs, Andrew
    Taylor, Matthew
    Mumby-Croft, Juliet
    Woodcock, Fionn
    Lacey, Michael
    Haroun, Rola
    Deschaseaux, Celine
    HEART, 2018, 104 (12) : 1006 - 1013
  • [28] Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction
    Jackson, Alice M.
    Jhund, Pardeep S.
    Anand, Inder S.
    Duengen, Hans-Dirk
    Lam, Carolyn S. P.
    Lefkowitz, Marty P.
    Linssen, Gerard
    Lund, Lars H.
    Maggioni, Aldo P.
    Pfeffer, Marc A.
    Rouleau, Jean L.
    Saraiva, Jose F. K.
    Senni, Michele
    Vardeny, Orly
    Wijkman, Magnus O.
    Yilmaz, Mehmet B.
    Saito, Yoshihiko
    Zile, Michael R.
    Solomon, Scott D.
    McMurray, John J., V
    EUROPEAN HEART JOURNAL, 2021, 42 (36) : 3741 - +
  • [29] Impact of Sacubitril-Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction
    Pericas, Pere
    Mas-Llado, Caterina
    Ramis-Barcelo, Maria Francisca
    Valadron, Isabel
    Noris Mora, Marta
    Pasamar Marquez, Lucia
    Gonzalez Colino, Rosa
    Forteza Alberti, Jose Francisco
    Peral Disdier, Vicente
    Rossello, Xavier
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (02) : 167 - 175
  • [30] Use of phenomapping to determine response of treatment by sacubitril/valsartan in patients with heart failure with reduced ejection fraction
    Godet, M.
    Raitiere, O.
    Chopra, H.
    Guignant, P.
    Fauvel, C.
    Gaudin, K.
    Eltchaninoff, H.
    Beuer, F.
    EUROPEAN HEART JOURNAL, 2019, 40 : 735 - 735